Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model"
ACS Pharmacol Transl Sci. 2024 Jan 3;7(1):298-299.
doi: 10.1021/acsptsci.3c00364.
eCollection 2024 Jan 12.